[1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof

US11919896B2 · kind B2 · utility

Assignee

• ZHUHAI UNITED LABORATORIES CO., LTD. · CN

Inventors

• Weiwei MAO · 安丰镇, CN
• Wenyuan Qian · Newbury Park, US
• Xuejian Zheng · Shanghai, CN
• Guoping HU · Shanghai, CN
• Changqing Wei · Shanghai, CN
• Jian Li · Shanghai, CN
• Shuhui CHEN · Shanghai, CN

Key dates

• Filing date: Aug 23, 2019
• Grant date: Mar 5, 2024
• Expiry date: Mar 20, 2041

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed are a [1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and an application thereof in preparing a drug for treating a disease related to JAK1 or/and TYK2. Specifically, the present invention relates to a compound represented by formula (I), or an isomer or pharmaceutically acceptable salt thereof. (I)